chlordiazepoxide has been researched along with fluoxetine in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (4.55) | 18.7374 |
| 1990's | 3 (13.64) | 18.2507 |
| 2000's | 12 (54.55) | 29.6817 |
| 2010's | 6 (27.27) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Feldman, RS; Smith, WC | 1 |
| Muscat, R; Papp, M; Willner, P | 1 |
| Baker, G; McGregor, A; Roberts, DC | 1 |
| Meert, TF | 1 |
| Ferris, CF; King, JA; Messenger, T | 1 |
| Leander, JD; Wolff, MC | 1 |
| Duxon, MS; Jones, N; King, SM | 1 |
| Gower, AJ; Lamberty, Y | 1 |
| Barsvári, B; Haller, J; Levay, G; Leveleki, C; Mikics, E; Soproni, K; Sziray, N | 1 |
| Bechtholt, AJ; Lucki, I; Valentino, RJ | 1 |
| Beyer, CE; Dwyer, JM; Leonard, SK; Logue, SF; Malberg, JE; Neal, SJ; Platt, B; Ring, RH; Rosenzweig-Lipson, S; Schechter, LE; Sukoff Rizzo, SJ | 1 |
| Balu, DT; Hoshaw, BA; Lucki, I; Malberg, JE; Rosenzweig-Lipson, S; Schechter, LE | 1 |
| Neill, JC; Snigdha, S | 1 |
| Acevedo, EO; Huang, CJ; Sufka, KJ; Warnick, JE | 1 |
| Georgievskava, Z; Georgievsky, I; Marshall, KP | 1 |
| Fitzgerald, PJ; Hefner, KR; Holmes, A; Ihne, JL | 1 |
2 review(s) available for chlordiazepoxide and fluoxetine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Social reactions to Valium and Prozac: a cultural lag perspective of drug diffusion and adoption.
Topics: Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Chlordiazepoxide; Culture; Diazepam; Drug Industry; Fluoxetine; History, 20th Century; History, 21st Century; Humans; Marketing; Public Opinion; Social Environment | 2009 |
20 other study(ies) available for chlordiazepoxide and fluoxetine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Chlordiazepoxide-fluoxetine interactions on food intake in free-feeding rats.
Topics: Animals; Chlordiazepoxide; Drug Interactions; Feeding Behavior; Fluoxetine; Male; Propylamines; Rats | 1978 |
Reversal of stress-induced anhedonia by the atypical antidepressants, fluoxetine and maprotiline.
Topics: Animals; Antidepressive Agents, Second-Generation; Chlordiazepoxide; Conditioning, Operant; Dopamine; Eating; Feeding Behavior; Fluoxetine; Food; Male; Maprotiline; Rats; Reward; Stress, Psychological; Sucrose | 1992 |
Effect of 6-hydroxydopamine lesions of the amygdala on intravenous cocaine self-administration under a progressive ratio schedule of reinforcement.
Topics: 3,4-Dihydroxyphenylacetic Acid; 5,7-Dihydroxytryptamine; Amygdala; Analysis of Variance; Animals; Behavior, Animal; Benzazepines; Brain; Chlordiazepoxide; Cocaine; Desipramine; Dopamine; Estrus; Female; Fluoxetine; Ibotenic Acid; Injections, Intravenous; Male; Organ Specificity; Oxidopamine; Rats; Rats, Wistar; Self Administration; Time Factors; Tryptophan | 1994 |
Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference.
Topics: Alcohol Drinking; Alcoholism; Animals; Buspirone; Chlordiazepoxide; Citalopram; Dose-Response Relationship, Drug; Drinking; Fluoxetine; Male; Ondansetron; Rats; Receptors, Serotonin; Ritanserin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists | 1993 |
Seed finding in golden hamsters: a potential animal model for screening anxiolytic drugs.
Topics: Adrenergic alpha-Agonists; Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Appetitive Behavior; Behavior, Animal; Buspirone; Chlordiazepoxide; Clozapine; Cricetinae; Desipramine; Drug Evaluation, Preclinical; Fasting; Fluoxetine; Injections, Intraperitoneal; Male; Mesocricetus; Models, Animal; Stress, Psychological; Yohimbine | 2002 |
Selective serotonin reuptake inhibitors decrease impulsive behavior as measured by an adjusting delay procedure in the pigeon.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Alprazolam; Analysis of Variance; Animals; Anti-Anxiety Agents; Chlordiazepoxide; Columbidae; Cyclohexanes; Dose-Response Relationship, Drug; Fluoxetine; Impulsive Behavior; Male; Piperazines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Reinforcement Schedule; Reward; Selective Serotonin Reuptake Inhibitors; Serotonin Receptor Agonists; Time Factors | 2002 |
Further evidence for the predictive validity of the unstable elevated exposed plus-maze, a behavioural model of extreme anxiety in rats: differential effects of fluoxetine and chlordiazepoxide.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Chlordiazepoxide; Dose-Response Relationship, Drug; Escape Reaction; Exploratory Behavior; Fluoxetine; Male; Maze Learning; Models, Animal; Rats; Rats, Inbred BN; Reproducibility of Results; Time Factors | 2002 |
Hydroxyzine prevents isolation-induced vocalization in guinea pig pups: comparison with chlorpheniramine and immepip.
Topics: Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Chlordiazepoxide; Chlorpheniramine; Dose-Response Relationship, Drug; Fluoxetine; Guinea Pigs; Histamine Agonists; Histamine H1 Antagonists; Hydroxyzine; Hypnotics and Sedatives; Imidazoles; Imipramine; Piperidines; Social Isolation; Vocalization, Animal | 2004 |
Pharmacological evaluation of the stress-induced social avoidance model of anxiety.
Topics: Animals; Anti-Anxiety Agents; Anxiety Disorders; Brain; Buspirone; Chlordiazepoxide; Diazepam; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Stimulation; Fluoxetine; Haloperidol; Male; Models, Neurological; Motor Activity; Phobic Disorders; Piperazines; Rats; Rats, Wistar; Reproducibility of Results; Serotonin Receptor Agonists; Stress, Psychological | 2006 |
Overlapping and distinct brain regions associated with the anxiolytic effects of chlordiazepoxide and chronic fluoxetine.
Topics: Analysis of Variance; Animals; Anti-Anxiety Agents; Behavior, Animal; Brain; Brain Mapping; Chlordiazepoxide; Dose-Response Relationship, Drug; Drug Administration Schedule; Feeding Behavior; Fluoxetine; Gene Expression Regulation; Male; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 2008 |
Pharmacology of neuropeptide S in mice: therapeutic relevance to anxiety disorders.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Anxiety Disorders; Arousal; Body Temperature Regulation; Calcium; Cell Line; Chlordiazepoxide; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Fear; Fluoxetine; Humans; In Vitro Techniques; Male; Maze Learning; Mice; Motor Activity; Neuropeptides; Oxytocin; Peptide Fragments; Receptors, Cell Surface; Receptors, G-Protein-Coupled; Structure-Activity Relationship | 2008 |
Differential regulation of central BDNF protein levels by antidepressant and non-antidepressant drug treatments.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Brain-Derived Neurotrophic Factor; Central Nervous System; Chlordiazepoxide; Desipramine; Electroshock; Fluoxetine; Male; Monoamine Oxidase Inhibitors; Phenelzine; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2008 |
Improvement of phencyclidine-induced social behaviour deficits in rats: involvement of 5-HT1A receptors.
Topics: Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Chlordiazepoxide; Female; Fluoxetine; GABA Modulators; Phencyclidine; Piperazines; Pyridines; Quinolones; Rats; Receptor, Serotonin, 5-HT1A; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Social Behavior Disorders | 2008 |
Modelling the anxiety-depression continuum in chicks.
Topics: Animals; Animals, Newborn; Anti-Anxiety Agents; Antidepressive Agents; Anxiety; Chickens; Chlordiazepoxide; Clonidine; Depression; Disease Models, Animal; Dose-Response Relationship, Drug; Fluoxetine; Imipramine; Interleukin-6; Maprotiline; Social Isolation; Stress, Psychological | 2009 |
Pharmacological modulation of stress-induced behavioral changes in the light/dark exploration test in male C57BL/6J mice.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents; Body Weight; Central Nervous System Stimulants; Chlordiazepoxide; Corticosterone; Disease Models, Animal; Emotions; Exploratory Behavior; Fluoxetine; Light; Lithium Chloride; Male; Methylphenidate; Mice; Mice, Inbred C57BL; Restraint, Physical; Stress, Psychological; Swimming | 2012 |